Rhelion Life Sciences Corp. has officially changed its corporate name from Red Light Holland Corp. and updated its ticker symbol on the Canadian Securities Exchange to RHEL, effective August 7, 2026. This rebranding reflects the company's strategic shift towards becoming a science-driven life sciences firm focused on developing naturally derived psychedelic medicines, following its acquisition of Filament Health. The new identity aligns with its expanding clinical programs and pharmaceutical capabilities. The company continues to advance natural psychedelic drug discovery and clinical research globally, aiming to create long-term shareholder value.
An unauthorized party exploited the SingularityNET bridge infrastructure, withdrawing about $1.56 million worth of FET tokens. Fetch.ai confirmed its own contracts remain secure and unaffected, but paused AGIX-to-FET conversions and the Ethereum-side...
Hyperliquid, a decentralized perpetuals exchange, reached an all-time high open interest of $8.1 billion on September 20, 2026, representing about 10.9% of the global perpetual futures market. This milestone was driven by the launch of tokenized trad...
Bitcoin recovered from $75,000 to nearly $82,000 last week, driven by institutional demand and short position liquidations. However, the price hit strong resistance between $81,500 and $82,300, limiting further gains. Geopolitical tensions in the Mid...
Zama (ZAMA) surged 27% to a new all-time high of $0.092 before slightly retracing to around $0.086, driven by strong buying pressure and increased market activity. The altcoin's market cap surpassed $200 million, with daily trading volume rising 149%...
Paradex, a decentralized derivatives exchange on Starknet, executed a record $15.76 million ETH options trade with a premium cost lower than centralized exchange Deribit. This milestone followed Paradex's integration of Paradigm's RFQ liquidity netwo...
